EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Sexual Dimorphism in Cardiometabolic Diseases: From Development to Senescence and Therapeutic Approaches

Thea Chevalley iD, Marion Dübi, Laurent Fumeaux iD, Maria Serena Merli, Alexandre Sarre iD, Natacha Schaer, Umberto Simeoni iD, Catherine Yzydorczyk iD

Cells · 2025

DOI: 10.3390/cells14060467 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2025. Verfasst von Thea Chevalley und 7 weiteren Autor:innen. Beteiligte Einrichtung: Developmental Origins of Health and Disease (DOHaD) Laboratory, Division of Pediatrics, Department Woman-Mother-Child, Lausanne University Hospital, …. Hauptthemen laut MEDLINE: Sex Characteristics, Cardiovascular Diseases, Metabolic Diseases, Aging. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 573 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss Heart Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The global incidence and prevalence of cardiometabolic disorders have risen significantly in recent years. Although lifestyle choices in adulthood play a crucial role in the development of these conditions, it is well established that events occurring early in life can have an important effect. Recent research on cardiometabolic diseases has highlighted the influence of sexual dimorphism on risk factors, underlying mechanisms, and response to therapies. In this narrative review, we summarize the current understanding of sexual dimorphism in cardiovascular and metabolic diseases in the general population and within the framework of the Developmental Origins of Health and Disease (DOHaD) concept. We explore key risk factors and mechanisms, including the influence of genetic and epigenetic factors, placental and embryonic development, maternal nutrition, sex hormones, energy metabolism, microbiota, oxidative stress, cell death, inflammation, endothelial dysfunction, circadian rhythm, and lifestyle factors. Finally, we discuss some of the main therapeutic approaches, responses to which may be influenced by sexual dimorphism, such as antihypertensive and cardiovascular treatments, oxidative stress management, nutrition, cell therapies, and hormone replacement therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sex CharacteristicsCardiovascular DiseasesMetabolic DiseasesAgingHumansFemaleMaleAnimalsOxidative StressPregnancy

Stichwörter der Autor:innen

cardiovascular diseasecardiovascular therapiesdevelopmental origins of health and diseasemetabolic diseasesexual dimorphism

Autor:innen und Institutionen

  • Developmental Origins of Health and Disease (DOHaD) Laboratory, Division of Pediatrics, Department Woman-Mother-Child, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland.

ORCID-Profile: Thea Chevalley, Laurent Fumeaux, Alexandre Sarre, Umberto Simeoni, Catherine Yzydorczyk

Förderung

  • Swiss Heart Foundation

Zitieren

APA

Chevalley, T., Dübi, M., Fumeaux, L., Merli, M. S., Sarre, A., Schaer, N., Simeoni, U., & Yzydorczyk, C. (2025). Sexual Dimorphism in Cardiometabolic Diseases: From Development to Senescence and Therapeutic Approaches. Cells. https://doi.org/10.3390/cells14060467

Vancouver

Chevalley T, Dübi M, Fumeaux L, Merli MS, Sarre A, Schaer N, et al. Sexual Dimorphism in Cardiometabolic Diseases: From Development to Senescence and Therapeutic Approaches. Cells. 2025. doi:10.3390/cells14060467

BibTeX
@article{Chevalley2025,
  author = {Chevalley, Thea and Dübi, Marion and Fumeaux, Laurent and Merli, Maria Serena and Sarre, Alexandre and Schaer, Natacha and Simeoni, Umberto and Yzydorczyk, Catherine},
  title = {Sexual Dimorphism in Cardiometabolic Diseases: From Development to Senescence and Therapeutic Approaches},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14060467}
}
Kostenlos starten →